Latest Secondary Market News

Noumi Limited lifted FY26 revenue by 8.8% and adjusted operating EBITDA by 7.6%, driven by Dairy & Nutritionals' strong earnings and strategic investments in Plant-based Milks. The company faces refinancing uncertainty with $610 million convertible notes maturing in May 2027, prompting a proposed acquisition by majority shareholder Arrovest.

Global X Metal Securities Australia Limited has issued a prospectus for five classes of securities tracking gold, silver, platinum, palladium, and a precious metals basket. The securities are physically backed, traded on ASX under AQUA Rules, and managed by JPMorgan Chase Bank.

Global X Metal Securities Australia Limited has refreshed its prospectus for five classes of precious metals securities, maintaining physical bullion backing and ASX AQUA listing, with detailed disclosures on structure, fees, risks, and tax implications.

Westpac has completed the $15.4 billion sale of its RAMS mortgage portfolio to a consortium including Pepper Money, KKR, and PIMCO, lifting its capital ratio and simplifying operations.

VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for its suite of 27 ETFs on the ASX, updating investment strategies, fee structures, risk factors, and operational details.

Island Pharmaceuticals is progressing its broad-spectrum antiviral Galidesivir amid a severe Ebola outbreak, securing government approvals in Uganda and outlining a dual clinical and regulatory development pathway targeting multiple deadly filoviruses.

Summerset Group maintained stable new sales in Q2 2026 with a notable 26% jump in resales, while prudently reducing its New Zealand build rate in response to economic uncertainty.

Vanguard Investments Australia has released estimated distribution amounts for 34 ETFs, covering a broad spectrum of asset classes, with payments scheduled for mid-July 2026.

Vanguard Investments Australia has announced estimated distributions for 34 of its ETFs, with payments scheduled for mid-July 2026. The payouts vary significantly across funds, reflecting diverse asset exposures and income profiles.

Ryman Healthcare has opened a NZ$100 million fixed rate bond offer maturing in 2032, featuring an exchange mechanism for existing bondholders and a minimum interest rate of 5.60%. The offer targets institutional and retail investors and aims to refinance debt and diversify funding.

Ryman Healthcare has launched a NZ$100 million fixed rate bond offer maturing in 2032, aiming to refinance existing debt and diversify its funding sources. The offer includes an exchange mechanism for existing bondholders, with trading in current bonds to be suspended during the transition.

VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for eight of its Australian ETFs, detailing investment strategies, fees, risks, and operational protocols under ASX AQUA Rules.